MPO and neoplasm: Pharmacological blockade of IL‐1 receptor (IL‐1R) decreased the primary growth of 4T1 tumours and reduced the systemic levels of myeloperoxidase, cell‐free DNA (cfDNA) and G‐CSF, without interfering with neutrophil counts.